0.6591
2.62%
0.0168
Athira Pharma Inc Azioni (ATHA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | - | - | - |
Research and Development |
10.32%
21.24
|
23.68 | 27.20 | 21.61 | 21.29 |
Costs And Expenses |
4.57%
27.69
|
29.01 | 35.04 | 31.64 | 29.77 |
Operating Income/Loss |
4.57%
-27.69
|
-29.01 | -35.04 | -31.64 | -29.77 |
Income/Loss From Continuing Operations Before Tax |
3.47%
-26.34
|
-27.29 | -35.04 | -29.60 | -27.82 |
Income/Loss From Continuing Operations After Tax |
3.47%
-26.34
|
-27.29 | -32.97 | -29.60 | -27.82 |
Net Income/Loss
|
3.47%
-26.34
|
-27.29 | -32.97 | -29.60 | -27.82 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
140.89K%
38.32
|
0.0272 | 38.05 | 38.00 | 37.92 |
Diluted Average Shares |
140.89K%
38.32
|
0.0272 | 38.05 | 38.00 | 37.92 |
Basic Earnings Per Share |
2.82%
-0.69
|
-0.71 | -0.87 | -0.78 | -0.73 |
Diluted Earnings Per Share |
2.82%
-0.69
|
-0.71 | -0.87 | -0.78 | -0.73 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):